A Korean SME, specialized in production of chemical medications with natural products, is seeking for partners to collaborate on EUREKA/Eurostar2 project proposal
Biological molecules are increasingly important as therapeutic agents, for example antibody-drug conjugates, but difficulties in production to the required amounts and quality remains a barrier
A Romanian company is preparing a project proposal under the call H2020 SME Instrument Phase 1, topic “Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well”